Michael Adam Fischer MD, MS

Dr. Fischer is a general internist, pharmacoepidemiologist, and health services, researcher. He is the Director of NaRCAD, which he and Dr. Jerry Avorn co-founded in 2010. In this role, he has obtained multiple grants to support NaRCAD’s core activities, the conference series, and additional research and implementation projects. More recently he has led NaRCAD in a range of public health collaborations focused on using AD to increase the use of HIV pre-exposure prophylaxis and to develop clinician-oriented responses to the opioid crisis.
< br/> Dr. Fischer is an Associate Professor of Medicine at Harvard and a clinically active primary care physician and educator at Brigham & Women’s Hospital. He has extensive experience in designing and evaluating interventions to improve medication use and has published numerous studies demonstrating the potential gains from improved prescribing. His research interests in addition to AD include prescription drug reimbursement policy, electronic prescribing, and medication adherence. Dr. Fischer earned his medical degree from the Yale School of Medicine and a Master of Science degree in health policy and management from the Harvard T.H. Chan School of Public Health. He completed residency training in primary care internal medicine at Brigham & Women’s Hospital. He teaches in both the outpatient and inpatient components of the internal medicine residency program at Brigham & Women’s and teaches courses on research methodology at the Harvard T.H. Chan School of Public Health, where he is an Associate Professor of Epidemiology.